A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer

~25 mi. (Kiel, Germany, +144 more cities)

GSK Investigational Site

Endometrial Carcinoma

carboplatin, +3 more drugs

chemotherapy, +2 more types

A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

~25 mi. (Kiel, Germany, +142 more cities)

Universitätsklinikum Schleswig

del(11)(q10), +27 more biomarkers

Myelofibrosis

imetelstat, +1 more drug

targeted therapy

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

~25 mi. (Kiel, Germany, +177 more cities)

University Medical Center chleswig- Campus Kiel

BCR-ABL1 Fusion, +1 more biomarker

Acute Lymphoblastic Leukemia

allogeneic hematopoietic stem cell transplantation, +18 more drugs

cellular therapy, +4 more types

A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

~25 mi. (Kiel, Germany, +156 more cities)

Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 201830

IGH-CCND1 Fusion, +1 more biomarker

Multiple Myeloma

dexamethasone, +1 more drug

chemotherapy, +1 more type

TAK-788 as First-line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

~25 mi. (Kiel, Germany, +144 more cities)

Stadtischen Krankenhaus Kiel

EGFR Exon 20 Insertion

Non-Squamous Non-Small Cell Lung Carcinoma

mobocertinib

targeted therapy

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

~25 mi. (Kiel, Germany, +29 more cities)

Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 161729

Cancer

chemotherapy, +1 more drug

chemotherapy

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

~67 mi. (Oldenburg in Holstein, Germany, +192 more cities)

Ostholstein Onkologie

ER Positive, +1 more biomarker

Breast Carcinoma

abemaciclib, +1 more drug

hormone therapy, +1 more type

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

~68 mi. (Stade, Germany, +94 more cities)

MVZ in der Klinik Dr. Hancken

HER2 Negative

Breast Carcinoma

sacituzumab govitecan

chemotherapy, +1 more type

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~69 mi. (Lübeck, Germany, +226 more cities)

Universitaetsklinikum Schleswig Holstein. ( Site 0346)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

~69 mi. (Lübeck, Germany, +140 more cities)

Universitaetsklinikum Schleswig-Holstein-Campus Lubeck ( Site 0215)

Hepatocellular Carcinoma

lenvatinib, +2 more drugs

chemotherapy, +2 more types

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

~69 mi. (Großhansdorf, Germany, +172 more cities)

LungenClinic Grosshansdorf

RET Fusion

Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

~69 mi. (Lübeck, Germany, +159 more cities)

Universitaetsklinikum Schleswig-Holstein-Campus Lubeck ( Site 0512)

Superficial Bladder Urothelial Carcinoma

cisplatin, +2 more drugs

chemotherapy, +1 more type